Related Experiment Videos
Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition
Carmen González1, Margarita Rubio, José Romero-Vivas
1Department of Clinical Microbiology, Hospital Universitario San Carlos, Madrid, Spain.
Summary
Nosocomial Staphylococcus aureus bacteremic pneumonia frequently affects intensive care unit patients. Community-acquired pneumonia is common in intravenous drug users, with similar outcomes for non-IV drug users regardless of acquisition source.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Staphylococcus aureus bacteremic pneumonia presents as either nosocomial (hospital-acquired) or community-acquired.
- Understanding the distinct clinical and epidemiological features of each is crucial for effective management.
Purpose of the Study:
- To characterize the clinical and epidemiological profiles of patients with nosocomial versus community-acquired Staphylococcus aureus bacteremic pneumonia.
- To identify risk factors and patient populations associated with each type of pneumonia.
Main Methods:
- A prospective study was conducted.
- 134 cases of Staphylococcus aureus bacteremic pneumonia were diagnosed between January 1990 and December 1995.
Main Results:
- Of 50 primary bacteremic pneumonias, 80% were nosocomial, predominantly in intensive care unit (ICU) patients (72%), many post-surgery (57%).
- Of 84 secondary pneumonias, 36 cases in non-intravenous drug users (IVDUs) were 78% nosocomial (43% in ICU).
- 48 cases in IVDUs were 98% community-acquired.
Conclusions:
- Nosocomial Staphylococcus aureus bacteremic pneumonia is highly prevalent in ICU patients (68.1%).
- Community-acquired pneumonia is common among IVDUs (72.3%).
- Clinical outcomes and mortality in non-IVDUs do not significantly differ between nosocomial and community-acquired Staphylococcus aureus bacteremic pneumonia.